Danaher Corp

$ 130.39 1.09 (0.84%)
Volume: 2,165,339 Avg Vol (1m): 3,465,031
Market Cap $: 93.35 Bil Enterprise Value $: 100.55 Bil
P/E (TTM): 38.47 P/B: 3.12
Earnings Power Value 45.29
Net Current Asset Value -16.34
Tangible Book -10.56
Projected FCF 76.1
Median P/S Value 58.34
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
YTD (-%)

Financial Strength : 6/10

Current vs industry vs history
Cash-to-Debt 0.41
Equity-to-Asset 0.61
Debt-to-Equity 0.30
Debt-to-EBITDA 2.00
Interest Coverage 23.90
Piotroski F-Score 6
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.17
DISTRESS
GREY
SAFE
Beneish M-Score -2.55
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 6.66%
WACC 7.54%

Profitability & Growth : 6/10

Current vs industry vs history
Operating Margin % 16.86
Net Margin % 12.04
ROE % 8.50
ROA % 4.99
ROC (Joel Greenblatt) % 84.17
3-Year Total Revenue Growth Rate -1.10
3-Year Total EBITDA Growth Rate 1.60
3-Year EPS w/o NRI Growth Rate 14.80

» DHR's 30-Y Financials

Financials (Next Earnings Date: 2019-07-19)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:DHR

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Diagnostics & Research » Diagnostics & Research    NAICS : 621511    SIC : 8071
Compare NYSE:TMO XAMS:PHIA NYSE:A NYSE:IQV TSE:6869 XSWX:LONN NYSE:LH NAS:IDXX NYSE:DGX XTER:SRT3 SZSE:300676 XPAR:BIM XPAR:ERF NYSE:PKI NYSE:BIO NYSE:QGEN NAS:DXCM NAS:ICLR NAS:EXAS XTER:AFX
Traded in other countries DHER34.Brazil DAP.Germany 0R2B.UK
Address 2200 Pennsylvania Avenue, North West, Suite 800W, Washington, DC, USA, 20037-1701
After the spin-off of Fortive in 2016, Danaher is a diversified and mostly healthcare-focused instrument and supplies manufacturer. After the spin, Danaher retains four main business segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. Each segment represents approximately 31%, 32%, 15%, and 22% of revenue, respectively.

Ratios

Current vs industry vs history
PE Ratio (TTM) 38.47
Forward PE Ratio 26.95
N/A
PE Ratio without NRI 38.47
Price-to-Owner-Earnings 29.06
PB Ratio 3.12
PS Ratio 4.62
Price-to-Free-Cash-Flow 28.82
Price-to-Operating-Cash-Flow 23.82
EV-to-EBIT 29.18
EV-to-EBITDA 21.16
EV-to-Revenue 5.00
Shiller PE Ratio 35.50
Current Ratio 2.18
Quick Ratio 1.74
Days Inventory 81.21
Days Sales Outstanding 61.98
Days Payable 68.77

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 0.50
Dividend Payout Ratio 0.19
3-Year Dividend Growth Rate (Per Share) 5.80
Forward Dividend Yield % 0.53
N/A
Yield-on-Cost (5-Year) % 2.19
3-Year Share Buyback Rate -0.70

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 1.71
Price-to-Median-PS-Value 2.24
Earnings Yield (Joel Greenblatt) % 3.43
Forward Rate of Return (Yacktman) % 3.37

More Statistics

Revenue (TTM) (Mil) $ 20,077.5
EPS (TTM) $ 3.39
Beta 0.94
Volatility % 22.22
52-Week Range $ 94.59 - 134.5
Shares Outstanding (Mil) 715.93

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 6
Positive ROA Y
Positive CFROA Y
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy Y
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy Y